What You Should Know:
- bttn, a company building next-generation healthcare supply distribution, announced a $20 million Series A led by Tiger Global with participation from seed investor Fuse.
- Born out of the COVID-19 pandemic, bttn was created to help solve the lack of medical supplies facing healthcare workers and improve access. The company has one lofty goal: to digitally transform the massive, antiquated $250B/year medical supply
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Unlocking Interoperability with a Blockchain-Powered Network
Achieving fluid data interoperability has been a complex and challenging goal for the U.S. healthcare system. The result of which has led to excessive administrative costs, delays in providing care, and significant patient frustration.
According to the Centers for Medicare and Medicaid Services, U.S. healthcare spending grew 9.7% in 2020, reaching $4.1 trillion, or $12,530 per person. This is forecasted to grow to $6.2 trillion by 2028, which will only exacerbate the current spending
Read More
Proscia Raises $37M for AI-Enabled Pathology Platform
What You Should Know:
- Proscia, a Philadelphia-based provider of digital and computational pathology solutions raises $37M to advance the way we understand and treat diseases like cancer. The round includes participation from Highline Capital Management, Triangle Peak Partners, and Alpha Intelligence Capital as well as existing investors including Scale Venture Partners, Hitachi Ventures, ROBO Global, Emerald Development Managers, and Razor's Edge Ventures. This investment brings Proscia's
Read More
ResMed Acquires MEDIFOX DAN for $1B, Expands Healthcare SaaS Business
What You Should Know:
- ResMed acquires MEDIFOX DAN, a German leader in software solutions for home health, nursing home, and outpatient therapy providers, for $1 billion. This acquisition marks ResMed’s largest SaaS acquisition to date and expands its SaaS business outside of the U.S. for the first time.
- As part of the acquisition, MEDIFOX DAN will integrate into ResMed’s SaaS business, allowing ResMed to serve new settings: outpatient therapy services, and youth
Read More
Wavemaker Three-Sixty Health Closes $64M Fund to Invest in Early-Stage Startups
What You Should Know:
- Wavemaker Three-Sixty Health (Wavemaker 360), the nation’s leading venture fund focused on early-stage (primarily seed) healthcare disruptors and innovators, recently announced its Fund II news, closing at $64M, surpassing its first fund nearly four times over.
- The goal for Fund II is to invest into 40-50 early-stage companies, with several investments already made into some of the most compelling healthcare start-ups in the areas of health-tech, digital health,
Read More
Syapse and Pierian Partner to Power Precision Oncology
What You Should Know:
- Syapse, a real-world evidence company is teaming up with Pierian®, a provider of advanced clinical genomics technology on a new joint collaboration that will benefit patients of the AdventHealth Cancer Institute in Central Florida.
- The collaboration combines Syapse’s real-world evidence solutions designed to improve outcomes for patients with cancer, Pierian’s leading-edge clinical genomics workflow, and precision medicine services that provide the most relevant
Read More
Invoca Raises $83M to Optimize Contact Center Experience
What You Should Know:
- Invoca, the cloud leader in AI-powered conversation intelligence for revenue teams" has raised $83M in its Series F at a $1.1B valuation led by
- With 6 of the top 10 U.S. health systems, 3 of the top 8 U.S. physical therapy clinics, and 4 of the top 6 U.S. dental service organizations already using Invoca, this recent round of funding will help improve the contact center experience for healthcare organizations.
Addressing Healthcare Staffing
Read More
Capital Rx Raises $106M to End Drug Price Distortion
What You Should Know:
- Capital Rx, a health technology company changing the way prescription drugs are priced and patients are serviced raises $106M in a Series C round to end drug price distortion. The Series C round was led by B Capital with participation from General Catalyst and existing investors, Transformation Capital and Edison Partners, bringing the total amount raised to $175M.
- Capital Rx will continue to invest in the technology backbone for claims processing and benefit
Read More
4 Steps for Operationalizing the FDA’s Call To Improve Health Outcomes for All Patients
In April, FDA Commissioner Dr. Robert Califf laid out areas of challenge and opportunity when it comes to improving health outcomes, restoring public trust in science, and making the most of our ongoing investments in data analytics and clinical research. More specifically, Califf made clear that our current healthcare system is “very well aligned to improve outcomes for some people and not others.”
Califf went on to note that we need better mechanisms for evidence generation
Read More
H1 Adds $20M to Series C to Power Democratization of Global Healthcare Data
What You Should Know:
- H1, the connecting force for global healthcare professional, clinical, science, and research information, announced their Series C extension led by Goldman Sachs Asset Management, Menlo Ventures, Transformation Capital and Novartis Pharma AG, bringing the total Series C raise to over $120M.
- The news comes at a time when public markets are down and many other companies are doing down rounds. The extension allows H1’s valuation of $773M to stay constant,
Read More
